Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cardio-Oncology, VEGF Inhibitor Cardiotoxicity

Rena Bhatt

MD

🏢Johns Hopkins Hospital🌐USA

Cardiologist

30
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Rena Bhatt at Hopkins contributes to cardio-oncology research on cardiovascular toxicities of VEGFR/TKI therapies and other cancer agents, including the management of hypertension and QT prolongation associated with VEGFR inhibitors and other targeted agents. Her work on practical management algorithms for cardiovascular toxicities across cancer therapy classes contributes to evidence-based cardio-oncology practice.

Share:

🧪Research Fields 研究领域

VEGF inhibitor cardiovascular toxicity
tyrosine kinase inhibitor cardiac
QT prolongation cancer therapy
cancer therapy hypertension
cardio-oncology program

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Rena Bhatt 的研究动态

Follow Rena Bhatt's research updates

留下邮箱,当我们发布与 Rena Bhatt(Johns Hopkins Hospital)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment